News & Updates

Show Multimedia Only
Ultra-low dose EBRT feasible in primary cutaneous B-cell lymphoma Ultra-low dose EBRT feasible in primary cutaneous B-cell lymphoma

Ultra-low dose EBRT feasible in primary cutaneous B-cell lymphoma

23 Sep 2024

Patients with primary cutaneous B-cell lymphoma (PCBCL) treated with ultra-low dose external beam radiation therapy (EBRT) to 4 Gy total dose in two fractions experience durable local control without skin toxicity, reports a study.

23 Sep 2024
What fuels flu, pneumococcal vaccine hesitancy in SG?

What fuels flu, pneumococcal vaccine hesitancy in SG?

23 Sep 2024 byJairia Dela Cruz

In Singapore, influenza and pneumococcal vaccination coverage remains stubbornly low. Results of two separate analysis of a cross-sectional survey shed light on this concerning trend, highlighting the roles of vaccine knowledge and attitude, healthcare professionals, and social support in influencing vaccination decisions.

23 Sep 2024
IBD patients at high myocarditis risk for up to 20 years

IBD patients at high myocarditis risk for up to 20 years

21 Sep 2024

The risk of myocarditis appears to be elevated among patients with inflammatory bowel disease (IBD) for ≥20 years following diagnosis, suggests a study in Sweden. However, absolute risks remain low.

21 Sep 2024